Featured Article

Where is RBQM Heading in The Future With AI?

Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials. With experience at both CluePoints and Veeva, Young discusses AI’s role, transparency, and the future of risk management in clinical trials.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Download
Press Release
CluePoints Data and Knowledge Manager Appointed to ACT Editorial Advisory Board
  • King of Prussia, PA – November 5th, 2025: CluePoints, provider of leading statistical and AI-driven software...
Read More
Press Release
CluePoints Proven AI Innovation Earns Dual Recognition at SCDM and SCRIP Awards
  • The RBQM and AI leader wins the ‘Clinical Data Science Implementation Excellence Award’ at SCDM 2025...
Read More
Press Release
CluePoints Sponsored RBQMLive Returns for 2025
  • KING OF PRUSSIA, Pa., Sept. 23, 2025 /PRNewswire/ — CluePoints, the premier sponsor of RBQMLive and...
Read More